Loading…
Loading…
Direct answers by Dr. Shree Narayan Yadav (MBBS (KU), MD-Internal Medicine (NAMS), MSc Clinical Rheumatology (USW, UK), NMC 14227) — Consultant Physician & Joint and Autoimmune Disease Specialist at Kathmandu Neurology Clinic & Cognitive Center. Evidence-based, no fabricated outcomes.
Evidence level tagged
Each answer cites evidence level (established/emerging/expert-opinion) and links to related authority topics.
Inflammatory arthritis typically causes morning stiffness over 30–60 minutes, swelling that improves with activity rather than rest, and may come with fatigue or other-system symptoms. Osteoarthritis usually worsens with use, eases with rest, and has brief morning stiffness. Dr. Shree Narayan Yadav (NMC 14227) combines examination with serology and imaging to distinguish them — the difference changes treatment entirely.
Treat-to-target means setting a measurable goal — usually remission or low disease activity — checking progress at defined intervals, and adjusting therapy until the target is reached, rather than prescribing and hoping. It is the international standard of RA care. Dr. Shree Narayan applies treat-to-target with DMARD escalation, disease-activity scores and regular review at the clinic.
A useful rule: pain inside joints with swelling, morning stiffness, or multiple joints — especially with fatigue, rash or eye symptoms — is rheumatology (immune/inflammatory). A single joint problem after injury, or mechanical failure like a worn knee, is orthopedic. At the clinic both specialties practice, so a rheumatology workup can flow into surgical review when the picture is mixed — Dr. Shree Narayan and Dr. Bodh Raj Gautam coordinate within the same clinic.
Diet contributes but rarely causes gout alone — genetics and urate handling dominate. Recurrent attacks, tophi, or joint damage justify urate-lowering therapy (usually allopurinol), not just dietary advice. Dr. Shree Narayan manages gout as the crystal arthropathy it is: treat acute attacks properly, then target a serum-urate threshold to prevent recurrence — diet advice supports, never replaces, that plan.
Not necessarily. ANA is a screening test — positive results occur in healthy people and in many conditions. Lupus requires a pattern: specific symptoms plus supporting serology (dsDNA, complement) and sometimes biopsy. Over-reading a lone positive ANA causes unnecessary fear; under-reading early lupus delays care. Dr. Shree Narayan interprets serology in context rather than treating a lab number.
Axial spondyloarthritis (including ankylosing spondylitis) causes inflammatory back pain — worse at night and with rest, easing with activity, usually starting before age 45, sometimes with eye inflammation or psoriasis. It responds to exercise and targeted therapy including biologics when needed — not ordinary back-pain advice. Dr. Shree Narayan screens chronic back pain for spondyloarthritis features early.
Biologics transformed autoimmune disease care, but they suppress parts of immunity and need structured monitoring: screening for TB/hepatitis before starting, infection awareness, periodic blood tests, and vaccination planning. Used correctly they prevent joint destruction and disability. Dr. Shree Narayan's MSc in Clinical Rheumatology (USW, UK) covers exactly this protocolized biologic management.
Yes — fibromyalgia is a real, validated condition of disordered pain processing; it is not 'in your head.' Treatment that works: structured exercise progression, sleep and stress management, and medications that modulate pain pathways — not escalating painkillers or endless scans. Dr. Shree Narayan's approach is validation plus a graded, multi-modal plan rather than dismissal or over-medicalization.
Yes — conditions like lupus, RA and antiphospholipid syndrome interact with pregnancy: some medications must change before conception, disease activity ideally should be controlled 3–6 months prior, and certain antibody patterns need obstetric-rheumatology co-management. Planning ahead with Dr. Shree Narayan before conception substantially improves outcomes versus adjusting mid-pregnancy.
Autoimmune diseases often blend — joint inflammation with skin, kidney, blood or gland involvement (lupus, Sjogren's, mixed connective-tissue disease, undifferentiated connective-tissue disease). Overlap syndromes are common and treatable, but require organ-system screening, not just joint management. Dr. Shree Narayan's internal-medicine background suits exactly this whole-system assessment.
Content on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.